Baird Medical Investment Holdings Limited

BDMD · NASDAQ · Healthcare / Medical Devices

0.0905USD-0.02 (-15.66%)

Price History

Full chart

Market Stats

Previous Close0.1073

Open0.0981

Day Range0.0804 – 0.0989

52-Week Range0.6605 – 3.70

Volume11.43M

Market Cap24.53M

P/E (TTM)0.00

Forward P/E5.64

EPS-0.55

Dividend Yield0.00%

Beta-1.16

50-Day Avg1.08

200-Day Avg1.44

About

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. It has a strategic cooperation agreement with Tianjin Yuanshan Medical Technology Co., Ltd. to focus on global development and commercialization of next-generation IRE technologies. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMs. Haimei Wu
Employees146
HeadquartersBaide Building, Building 11, Guangzhou, China, USA
Websitehttps://bairdmed.com

Leadership

Ms. Haimei WuChairwoman of the Board of Directors & CEO · b. 1982
Ms. Quan QiuChief Administrative Officer & Executive Director · b. 1993
Mr. Wei HouExecutive Director · b. 1970
Ms. Jie LiActing Chief Financial Officer · b. 1988
Mr. Rongjian LuCTO & Deputy GM · b. 1967
Mr. Mark S. SaxtonChief Executive Officer U.S. Subsidiary · b. 1965

Financials

Income Statement

Currency: USD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	12.21M	18.12M	27.72M	35.09M	31.46M	37.04M	22.54M
Growth (%)	-	+48.39%	+52.99%	+26.58%	-10.35%	+17.74%	-39.15%
Cost of Revenue	1.30M	2.51M	4.54M	7.05M	4.23M	4.38M	3.65M
Gross Profit	10.91M	15.61M	23.18M	28.04M	27.23M	32.65M	18.88M
Gross Margin	89.37%	86.14%	83.61%	79.90%	86.56%	88.16%	83.79%
Operating Expense	5.30M	5.75M	11.26M	14.41M	15.37M	17.34M	44.42M
Operating Income	5.61M	9.86M	11.92M	13.63M	11.86M	15.32M	-25.54M
Operating Margin	45.94%	54.42%	42.99%	38.85%	37.71%	41.35%	-113.31%
EBITDA	5.85M	10.28M	14.16M	16.29M	12.88M	16.17M	-24.53M
EBITDA Margin	47.87%	56.74%	51.08%	46.43%	40.93%	43.66%	-108.86%
Net Income	-7.18M	7.10M	11.68M	12.57M	10.55M	12.45M	-27.28M
Net Income Margin	-58.83%	39.18%	42.12%	35.82%	33.52%	33.62%	-121.04%
R&D	1.16M	750.48K	1.04M	3.86M	4.27M	6.17M	20.13M
R&D as % of Total Revenue	9.47%	4.14%	3.75%	11.00%	13.59%	16.67%	89.32%
Interest Expense	89.62K	159.47K	153.92K	299.27K	284.27K	576.75K	737.37K
Interest Expense % of Total Revenue	0.73%	0.88%	0.56%	0.85%	0.90%	1.56%	3.27%

Balance Sheet

Currency: USD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	11.76M	17.02M	26.12M	42.62M	56.71M	77.96M	69.70M
Total Liabilities	34.33M	10.25M	10.26M	16.84M	21.00M	38.20M	38.48M
Total Equity	-21.89M	7.21M	5.20M	25.93M	35.75M	39.66M	31.37M
Cash	220.45K	1.07M	3.03M	1.71M	1.51M	2.97M	178.32K
Total Debt	28.94M	4.05M	2.93M	7.44M	9.90M	20.88M	19.30M
Net Debt	28.72M	2.98M	-97.60K	5.73M	8.39M	17.91M	19.12M

Cash Flow

Currency: USD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	4.41M	3.91M	5.26M	485.97K	-1.02M	-6.31M	-1.34M
Investing Cash Flow	1.18M	-2.17M	-1.39M	-5.92M	-2.64M	-2.85M	-42.31K
Financing Cash Flow	-5.72M	-899.08K	-1.93M	4.41M	3.46M	10.72M	-1.39M
Capital Expenditure	983.78K	655.35K	1.39M	5.95M	2.64M	2.85M	42.31K
Free Cash Flow	3.43M	3.25M	3.87M	-5.47M	-3.66M	-9.17M	-1.39M
Dividends Paid	-	-	5.43M	0	-	-	-
FCF to OCF	77.70%	83.23%	73.59%	-1125.21%	358.68%	145.20%	103.15%
Dividend Paid to FCF	-	-	140.29%	0.00%	-	-	-

Earnings

Report Date	Oct 5, 2021	Mar 31, 2022	May 13, 2022	Aug 15, 2022	Nov 14, 2022	Mar 30, 2023	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Nov 15, 2024	May 15, 2025	Dec 5, 2025
EPS Estimate	0.00	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00
EPS Actual	0.00	-0.02	-0.02	-0.01	0.01	0.03	0.05	-0.18	-0.16	-0.07	-0.20	-0.11	0.15	0.37	-0.43
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap24.53M

Enterprise Value39.20M

Trailing P/E0.00

Forward P/E5.64

Price / Sales1.00

Price / Book0.73

EPS-0.55

Book Value1.52

Revenue (TTM)24.49M

Gross Profit (TTM)20.97M

EBITDA-13.28M

Profit Margin-64.94%

Operating Margin8.54%

Return on Equity-46.03%

Return on Assets-11.88%

Shares Outstanding32.00M

Shares Float12.11M

Beta-1.16

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Ownership Breakdown

Institutions: 0.99%
Insiders: 85.54%
Retail / Other: 13.47%

Top Institutional Holders

Highbridge Capital Management, LLC
125.00K0.39%
UBS Group AG
67.86K0.21%
Two Sigma Investments LLC
55.50K0.17%
Citadel Advisors Llc
54.90K0.17%
Jane Street Group LLC
39.42K0.12%
NATIONAL BANK OF CANADA /FI/
28.48K0.09%
Geode Capital Management, LLC
25.44K0.08%
Morgan Stanley - Brokerage Accounts
20.00K0.06%
Wolverine Asset Management LLC
2050.00%
Periscope Capital Inc.
00.00%

Top Fund Holders

Fidelity Nasdaq Composite Index
19.60K0.06%